In our experience, the primary obstacle precluding the widespread use of orthotopic liver transplantation (OLT) for definitive therapy of hepatocellular carcinoma (HCC), even for early-stage disease, is preventing tumor recurrence. Chemoembolization is an attractive strategy to minimize tumor progre
Orthotopic Liver Transplantation for Preoperative Early-Stage Hepatocellular Carcinoma
โ Scribed by TAN, CHEE-KIAT; GORES, GREGORY J.; STEERS, JEFFERY L.; PORAYKO, MICHAEL K.; HAY, J. EILEEN; RAKELA, JORGE; WIESNER, RUSSELL H.; KROM, RUUD A.F.
- Book ID
- 121887805
- Publisher
- Mayo Clinic
- Year
- 1994
- Tongue
- English
- Weight
- 586 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0025-6196
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
patients who met the following criteria-hepatic tumor unresectable because of location or inadequate liver reserve, no metastases, HBsAg negative, no tumor larger than 5 cm in diameter, and no more than three tumors-were enrolled prospectively in a protocol employing preoperative chemoembolization t
## Key Points 1. Liver transplantation is currently an effective therapy for patients with HCC who meet the Milan criteria. 2. The proportion of patients on waiting lists for liver transplantation who have HCC has increased substantially in recent years. HCC is currently one of the major indicatio